Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Alfentanil for Conscious Sedation in the Emergency Department
NCT02358057Phase 4Completed
- Start
- Feb 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine and alfentanil in Procedural sedation (PS). Primary endpoint: Ramsay score scale at 2 hours. Started Feb 2015; status: completed.
02
Drugs
dexmedetomidinealfentanil
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT02358057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02358057.